Pharmaceutical Business Review
Return to: PBR Home | Companies

CTI BioPharma Corp

CTI BioPharma Corp
Suite 800
3101 Western Avenue
Seattle
United States of America
Phone: 1 206 2827100
Fax: 12-06-2846206
www.ctibiopharma.com

No. employees: 57
Turnover: 25.15 (US$m)
Financial year end: December

Company Overview

Top Competitors


Key Employees

Jack W. Singer, M.D.

Director, Executive Vice President, Chief Scientific Officer, Chief Medical Officer - Interim, Global Head - Translational Medicine, Executive Board

Adam R. Craig, M.D., Ph.D.

Director, President, Chief Executive Officer, Executive Board

Laurent Fischer, Ph.D

Chairman, Director, Executive Board

Reed V. Tuckson M.D.

Director, Non Executive Board

Frederick W. Telling Ph.D

Director, Non Executive Board

Matthew D. Perry

Director, Non Executive Board

Michael A. Metzger

Director, Non Executive Board

Richard L. Love

Director, Non Executive Board

David R. Parkinson, M.D.

Director, Non Executive Board

Bruce J. Seeley

Executive Vice President, Chief Commercial and Administrative Officer, Secretary, Senior Management

David H. Kirske

Chief Financial Officer, Executive Vice President, Senior Management

Bruce J. Seeley

Chief Operating Officer, Executive Vice President, Senior Management

Locations/Subsidiaries


Suite 800,
3101 Western Avenue,
Seattle,
Washington,
United States of America
Phone: 1 206 2827100
Fax: 1 206 2846206

CTI Life Sciences Ltd

Highlands House Basingstoke Road, Spencers Wood ,
Reading,
Berkshire,
United Kingdom

Aequus BioPharma Inc

Suite 600,
3101 Western Ave.,
Seattle,
Washington,
United States of America
Phone: 1 206 8553397

Products/Services


Products:

  • Pixantrone - Multiply Relapsed or Refractory Aggressive B-cell NHL
  • Product Pipeline:
  • Pacritinib
  • PERSIST-1: Myelofibrosis
  • PERSIST-2: Myelofibrosis
  • Relapsed Acute Myeloid Leukemia (AML)
  • Tosedostat - Relapsed/Refractory AML or Myelodysplastic Syndromes (MDS)
  • Paclitaxel poliglumex - Ovarian Cancer